| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.15 | 6e-06 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.27 | 7e-05 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.003 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.004 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.089 | 0.006 |